FDA investigating infant botulism outbreak linked to recalled formula

The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning outbreak of infant botulism affecting multiple states. The illness has been linked to specific batches of baby formula that have since been recalled.

Infant botulism, while rare, is a serious condition that can have severe consequences for affected infants. It occurs when babies ingest bacteria containing spores. These spores can then germinate and produce a potent toxin within the infant's digestive system, leading to illness.

CBS News medical correspondent Dr. Céline Gounder offered insights into the outbreak, shedding light on the potential risks and the ongoing efforts to understand the scope of the problem. The investigation aims to identify the source of contamination and ensure the safety of infant nutrition products.

Health officials are urging parents to remain vigilant and to follow recall instructions carefully. The FDA's investigation is critical in determining the full extent of the contamination and preventing further cases of this dangerous illness.